Ergine
| LAA, LA-111 | |
|---|---|
 | |
| Molecular structure via molpic based on CDK |
| Physical properties [] | |
|---|---|
| Molecular mass | 267.33 g/mol [1] |
| Predicted LogP | 1.6 [1] |
| Structural Identifiers [] | |
|---|---|
| Molecular formula | C16H17N3O [1] |
| IUPAC name | (6aR,9R)-7-methyl-6,6a,8,9-tetrahydro-4H-indolo[4,3-fg]quinoline-9-carboxamide [1] |
| SMILES | CN1C[C@@H](C=C2[C@H]1CC3=CNC4=CC=CC2=C34)C(=O)N [1] |
| InChI | InChI=1S/C16H17N3O/c1-19-8-10(16(17)20)5-12-11-3-2-4-13-15(11)9(7-18-13)6-14(12)19/h2-5,7,10,14,18H,6,8H2,1H3,(H2,17,20)/t10-,14-/m1/s1 [1] |
| InChIKey | GENAHGKEFJLNJB-QMTHXVAHSA-N [1] |
| Pharmacokinetics[] | |
|---|---|
| Duration of action | 4 – 10 h (morning glory|morn. glory seeds)[4] |
Ergine (also known as Lysergamide, CHEBI:4819, 9,10-didehydro-6-methylergoline-8 β-carboxamide, (8R)-9,10-didehydro-6-methylergoline-8-carboxamide, (6aR,9R)-7-methyl-6,6a,8,9-tetrahydro-4H-indolo(4,3-fg)quinoline-9-carboxamide, 207-524-0, Ergine, 9,10-Didehydro-6-methylergoline-8β-carboxamide, (6aR,9R)-7-methyl-4,6,6a,7,8,9-hexahydroindolo[4,3-fg]quinoline-9-carboxamide or Lyergic acid amide) is a psychedelic substance of the lysergamide class.
Chemistry
Stereochemistry []
Ergine is a absolute mixture.
Legal status []
- Brazil: Ergine is a F2 substance.[3]
- Germany: Ergine is a Neuer-Psychoaktiver-Stoff under the "Neue-psychoaktive-Stoffe-Gesetz (NpSG)".
- United Kingdom: Ergine is a Class A substance.
- United States: Ergine is a Schedule I under the "Controlled Substances Act (CSA)".
See also []
External links []
References []
National Center for Biotechnology Information. PubChem Compound Summary for CID 442072, Lysergamide. Accessed May 17, 2026. https://pubchem.ncbi.nlm.nih.gov/compound/442072
U.S. Food and Drug Administration; National Center for Advancing Translational Sciences. Ergine. UNII: 073830XH10. Global Substance Registration System. Accessed May 17, 2026. https://gsrs.ncats.nih.gov/ginas/app/beta/substances/073830XH10
Anvisa. RDC Nº 804 - Listas de Substâncias Entorpecentes, Psicotrópicas, Precursoras e Outras sob Controle Especial. Diário Oficial da União. July 24, 2023. Accessed May 17, 2026. https://www.in.gov.br/en/web/dou/-/resolucao-rdc-n-804-de-24-de-julho-de-2023-498447451
Tittarelli R, Mannocchi G, Pantano F, Romolo FS. Recreational use, analysis and toxicity of tryptamines. Curr Neuropharmacol. January 1, 2015; 13(1):26–46.